DETERMINATION OF THE TRANSCRIPT OF THE CHEMICAL BCR-ABL P210 GENE IN PATIENTS WITH ACUTE LEUKEMIAS AND EVALUATION OF THE CLINICAL AND LABORATORY SYMPTOMS.
Scientific and Innovative Therapy · 2026 · 5 (2) · 496-515
DOI: 10.64582/ivit.uz.692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2026. Verfasst von Нодира Tuychibayeva und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This article presents the features of the course of acute leukemias and the results of assessing the role of genetic analysis in their diagnosis. The results showed that in the clinical picture of acute leukemia, anemic symptoms were noted in 92.1% of cases, infectious complications - in 61.9%, tumor intoxication syndrome - in 44.4% of patients, which indicates that the process occurred due to the weakening of the body's immune system. The study showed that determining BCR-ABL p210 by molecular genetic methods, namely quantitative PCR (qPCR), is a more accurate approach compared to the cytogenetic study of the Ph chromosome.
Zitieren
APA
Tuychibayeva, Н., & Jumayeva, М. (2026). DETERMINATION OF THE TRANSCRIPT OF THE CHEMICAL BCR-ABL P210 GENE IN PATIENTS WITH ACUTE LEUKEMIAS AND EVALUATION OF THE CLINICAL AND LABORATORY SYMPTOMS. Scientific and Innovative Therapy, 5(2), 496-515. https://doi.org/10.64582/ivit.uz.692
Vancouver
Tuychibayeva Н, Jumayeva М. DETERMINATION OF THE TRANSCRIPT OF THE CHEMICAL BCR-ABL P210 GENE IN PATIENTS WITH ACUTE LEUKEMIAS AND EVALUATION OF THE CLINICAL AND LABORATORY SYMPTOMS. Scientific and Innovative Therapy. 2026;5(2):496-515. doi:10.64582/ivit.uz.692
BibTeX
@article{Tuychibayeva2026,
author = {Tuychibayeva, Нодира and Jumayeva, Мафтуна},
title = {DETERMINATION OF THE TRANSCRIPT OF THE CHEMICAL BCR-ABL P210 GENE IN PATIENTS WITH ACUTE LEUKEMIAS AND EVALUATION OF THE CLINICAL AND LABORATORY SYMPTOMS},
journal = {Scientific and Innovative Therapy},
year = {2026},
volume = {5},
number = {2},
pages = {496--515},
doi = {10.64582/ivit.uz.692}
}
EUVIMED